In this issue:
Elevated NT-proBNP as a CV disease risk equivalent
Structural cardiac abnormalities in patients with AF/flutter and myocardial injury
Subcutaneous vs transvenous ICDs
Longer-term all-cause and CV mortality after intensive BP control
Management of patients with recurrent traumatic syncope and bifascicular block
Single point-of-care hs-cTnI measurement to rule out acute MI
Once-weekly tirzepatide for the treatment of obesity
DOACs vs VKAs in patients with thrombotic antiphospholipid syndrome
Sodium restriction in patients with heart failure
Impact of BP reduction in patients with isolated diastolic hypertension
Please login below to download this issue (PDF)